Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Triptolide |
Synonyms | |
Therapy Description |
Triptolide (C1572) is a plant-derived small molecule that reduces MYC protein expression, and may decrease cancer stem cell number and tumor growth (PMID: 28951456). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Triptolide | C1572 | Triptolide (C1572) is a plant-derived small molecule that reduces MYC protein expression, and may decrease cancer stem cell number and tumor growth (PMID: 28951456, PMID: 32775615). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
Unknown unknown | triple-receptor negative breast cancer | not applicable | Triptolide | Preclinical - Cell line xenograft | Actionable | In a preclinical study, treatment with Triptolide (C1572) decreased Myc protein expression, decreased cancer stem-like cell (CSC) number, and induced senescence in a triple-negative breast cancer (TNBC) cell line in culture, and depleted CSCs and reduced tumor growth in TNBC cell line xenograft models (PMID: 28951456). | 28951456 |
Unknown unknown | gastric adenocarcinoma | not applicable | Triptolide | Preclinical - Cell culture | Actionable | In a preclinical study, treatment with Triptolide (C1572) induced apoptotic cell death and resulted in decreased cell viability in gastric adenocarcinoma cell lines in culture (PMID: 28192510). | 28192510 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|